Infectious complications in hairy cell leukemia

Leukemia and Lymphoma

Volumn 52, Issue SUPPL. 2, 2011, Pages 50-52

  Kraut, Eric ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

complications; Hairy cell leukemia; infections

Indexed keywords

CLADRIBINE; INTERFERON; PENTOSTATIN; RITUXIMAB;

ARTICLE; CANCER CHEMOTHERAPY; FEBRILE NEUTROPENIA; HAIRY CELL LEUKEMIA; HERPES ZOSTER; HUMAN; INFECTIOUS COMPLICATION; MONOCYTOPENIA; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SPLENECTOMY;

HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSION; LEUKEMIA, HAIRY CELL; OPPORTUNISTIC INFECTIONS;

EID: 79957495047     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.570819     Document Type: Article

References (24)

1. Golomb HM, Hadad L. Infectious complications in 127 patients with hairy cell leukemia. Am J Hematol 1984;16:393-401. (Pubitemid 14146708)
2. Stewart DJ, Bodey GP. Infections in hairy cell leukemia. Cancer 1981;15:801-805.
3. Bouza E, Burgeleta C, Golde DW. Infections in hairy cell leukemia. Blood 1978:51 851-859.
4. Dasanu CA, Ichim TE, Alexandrescu DT. Inherent and iatrogenic immune defects in hairy cell leukemia revisited. Expert Opin Drug Saf 2010;9:55-59.
5. Grever M, Kopecky K, Foucar MK, et al. Randomized comparison of pentostatin and interferon alpha-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol 1995;4:974-982.
6. Maloisel F, Benboubker L, Gardembas M, et al. Long term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Leukemia 2003;17:45-51.
7. Catovsky D, Matues E, Talavera JG, et al. Long term results with 20deoxycoformycin in hairy cell leukemia. Leuk Lymphoma 1994;14(Suppl. 1):109-113. (Pubitemid 24282604)
8. Rafel M, Cervantes F, Beltran JM, et al. Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients. Cancer 2000;88: 352-357. (Pubitemid 30051819)
9. Riberio, P, Bouaffia F, Peaud PY, et al. Long term outcome of patients treated with pentostatin. Cancer 1999;85:65-71. (Pubitemid 29031357)
10. Saven A, Burian C, Koziol JA, Piro LD. Long term followup of patients with hairy cell leukemia after treatment with cladribine. Blood 1998;92:1919-1926.
11. Hoffman MA, Janson D, Rose E, Rai KR. Treatment of hairy cell leukemia with cladribine response, toxicity and long term followup. J Clin Oncol 1997;15:1138-1142.
12. Cheson BD, Sorensen JM, Vena DA, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National CancerInstitute: a report of 979 patients. J Clin Oncol 1998;16: 3007-3015. (Pubitemid 28417420)
13. Robak T, Blasinkra-Morawicc M, Blonski J, et al. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia and hairy cell leukemia variant. Eur J Haemtol 1999; 62:49-56. (Pubitemid 29029918)
14. Tallman MS, Hakimian D, Variakojiis D, et al. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992; 80:2203-2209.
15. Smith JW, Longo DL, Urba WJ, et al. Prolonged continuous treatment of hairy cell leukemia patients with recombinant interferon-a-2a. Blood 1991;78:1664-1671.
16. Benz R, Siciliano RD, Stussi G, Fehr J. Long term followup of interferon-alpha induction and low dose maintenance therapy in hairy cell leukemia. Eur J Haematol 2009;82:194-198.
17. Damasio EE, Clavio M, Masoudi B, et al. Alpha interferon as induction and maintenance therapy in hairy cell leukemia. Eur J Haemtol 2000;64:47-52. (Pubitemid 30055543)
18. Nieva J, Bethel K, Saven A. Phase II study of rituximab in the treatment of cladribine failed patients with hairy cell leukemia. Blood 2003;102:810-813. (Pubitemid 36917768)
19. Thomas D, O'Brien S, Bueso-Ramos C, et al. Rituximab in relapsed or refractory hairy cell leukemia. Blood 2003;102: 3906-3911. (Pubitemid 37486969)
20. Hagberg H, Lundholm L. Rituximab, a chimaeric anti CD20 monoclonal antibody in the treatment of hairy cell leukemia Br J Haematol 2001;115:609-611.
21. Else M, Ruchlemer R, Osuji N, et al. Long remissions in patients with hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer 2005;104:2442-2448. (Pubitemid 41691566)
22. Huynh E, Sigal D, Saven A. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results Leuk Lymphoma 2009;50:12-17.
23. Flinn IW, Kopecky KJ, Foucar KM, et al. Long-term followup of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 2000;96:2981-2986.
24. Habermann TM, Anderson JW, Cassileth PA, et al. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia. Br J Haematol 1992;80:466-471.